Gene · 2921
Papers3,842
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 3,842
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Activation of the NFκB signaling pathway in IL6+CSF3+ vascular endothelial cells promotes the formation of keloids. | Front Bioeng Biotechnol | 2022 | 36082167 | PubTator, text mining | PubMed |
| Identification of Four Biomarkers of Human Skin Aging by Comprehensive Single Cell Transcriptome, Transcriptome, and Proteomics. | Front Genet | 2022 | 36081986 | PubTator, text mining | PubMed |
| Oncostatin M: From Intracellular Signaling to Therapeutic Targets in Liver Cancer. | Cancers (Basel) | 2022 | 36077744 | PubTator, text mining | PubMed |
| Dysregulated Expression of Three Genes in Colorectal Cancer Stratifies Patients into Three Risk Groups. | Cancers (Basel) | 2022 | 36077612 | PubTator, text mining | PubMed |
| Osteogenic Efficacy of Human Trophoblasts-Derived Conditioned Medium on Mesenchymal Stem Cells. | Int J Mol Sci | 2022 | 36077594 | PubTator, text mining | PubMed |
| Ewing Sarcoma and Osteosarcoma Have Distinct Immune Signatures and Intercellular Communication Networks. | Clin Cancer Res | 2022 | 36074145 | PubTator, text mining | PubMed |
| Tumor-associated macrophages in liver cancer: From mechanisms to therapy. | Cancer Commun (Lond) | 2022 | 36069342 | PubTator, text mining | PubMed |
| Exosome application in treatment and diagnosis of B-cell disorders: leukemias, multiple sclerosis, and arthritis rheumatoid. | Cell Mol Biol Lett | 2022 | 36064322 | PubTator, text mining | PubMed |
| Regulation of pancreatic cancer therapy resistance by chemokines. | Semin Cancer Biol | 2022 | 36064086 | PubTator, text mining | PubMed |
| Oncogene or tumor suppressor gene: An integrated pan-cancer analysis of NBPF1. | Front Endocrinol (Lausanne) | 2022 | 36060966 | PubTator, text mining | PubMed |
| Inflammasome activation as a link between obesity and thyroid disorders: Implications for an integrated clinical management. | Front Endocrinol (Lausanne) | 2022 | 36060941 | PubTator, text mining | PubMed |
| Macrophage polarization regulates intervertebral disc degeneration by modulating cell proliferation, inflammation mediator secretion, and extracellular matrix metabolism. | Front Immunol | 2022 | 36059551 | PubTator, text mining | PubMed |
| The Hippo-YAP pathway in various cardiovascular diseases: Focusing on the inflammatory response. | Front Immunol | 2022 | 36059522 | PubTator, text mining | PubMed |
| RNA-Seq transcriptome analysis reveals Maackia amurensis leukoagglutinin has antitumor activity in human anaplastic thyroid cancer cells. | Mol Biol Rep | 2022 | 36057880 | PubTator, text mining | PubMed |
| Probiotic-Based Bacteriocin: Immunity Supplementation Against Viruses. An Updated Review. | Front Microbiol | 2022 | 36033850 | PubTator, text mining | PubMed |
| Molecular and pathological subtypes related to prostate cancer disparities and disease outcomes in African American and European American patients. | Front Oncol | 2022 | 36033462 | PubTator, text mining | PubMed |
| Restoring Prohealing/Remodeling-Associated M2a/c Macrophages Using ON101 Accelerates Diabetic Wound Healing. | JID Innov | 2022 | 36017415 | PubTator, text mining | PubMed |
| Comparative transcriptome analysis of MDBK cells reveals that BoIFN-γ augmented host immune responses to bovine herpesvirus 1 infection. | Front Microbiol | 2022 | 36016774 | PubTator, text mining | PubMed |
| The Impact of Epitranscriptomics on Antiviral Innate Immunity. | Viruses | 2022 | 36016289 | PubTator, text mining | PubMed |
| The Chemokines CXC, CC and C in the Pathogenesis of COVID-19 Disease and as Surrogates of Vaccine-Induced Innate and Adaptive Protective Responses. | Vaccines (Basel) | 2022 | 36016187 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2921/papers?page=47